| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/12/2023 | -6.1% | Credit Suisse | $9 → $4 | Downgrades | Outperform → Neutral |
| 11/02/2022 | 111.27% | Credit Suisse | $10 → $9 | Maintains | Outperform |
| 10/12/2022 | 134.74% | Credit Suisse | → $10 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 838.97% | Canaccord Genuity | → $40 | Initiates Coverage On | → Buy |
What is the target price for Mynaric (MYNA)?
The latest price target for Mynaric (NASDAQ: MYNA) was reported by Credit Suisse on January 12, 2023. The analyst firm set a price target for $4.00 expecting MYNA to fall to within 12 months (a possible -6.10% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mynaric (MYNA)?
The latest analyst rating for Mynaric (NASDAQ: MYNA) was provided by Credit Suisse, and Mynaric downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Mynaric (MYNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mynaric, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mynaric was filed on January 12, 2023 so you should expect the next rating to be made available sometime around January 12, 2024.
Is the Analyst Rating Mynaric (MYNA) correct?
While ratings are subjective and will change, the latest Mynaric (MYNA) rating was a downgraded with a price target of $9.00 to $4.00. The current price Mynaric (MYNA) is trading at is $4.26, which is out of the analyst's predicted range.